Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengwen Li

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Blood Cancer Journal|July 10, 2026
Genomic landscape, clinical correlates and prognostic implications of U2AF1 mutation subtypes in myelodysplastic neoplasmsZefei Bao, Bing Li, Tiejun Qin, et al.
Pathology, Research and Practice|April 1, 2025
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasmsFuhui Li, Yudi Zhang, Chengwen Li, et al.
American Journal of Hematology|July 22, 2014
Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndromeRuixian Xing, Chengwen Li, Robert Peter Gale, et al.
Leukemia Research Reports|March 27, 2023
Case of cryptic <i>TNIP1::PDGFRB</i> rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapyShiqiang Qu, Yiru Yan, Chengwen Li, et al.
Cancers|August 28, 2025
Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple MyelomaChenxing Du, Jian Cui, Jingyu Xu, et al.
BMC Medical Genetics|February 18, 2017
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phaseDehui Zou, Shuhua Yi, Rui Cui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[A study of prognostic value of cytogenetics in patients with primary myelofibrosis]Bing Li, Junqing Xu, Zefeng Xu, et al.
Leukemia & Lymphoma|June 24, 2023
Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and <i>FGFR1</i> rearrangementYiru Yan, Shiqiang Qu, Jinqin Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2009
Cellular immune response to cryptic epitopes during therapeutic gene transferChengwen Li, Kevin Goudy, Matt Hirsch, et al.
American Journal of Hematology|August 19, 2014
Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosisBing Li, Junqing Xu, Chengwen Li, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Blood Cancer Journal|July 10, 2026
Genomic landscape, clinical correlates and prognostic implications of U2AF1 mutation subtypes in myelodysplastic neoplasmsZefei Bao, Bing Li, Tiejun Qin, et al.
Pathology, Research and Practice|April 1, 2025
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasmsFuhui Li, Yudi Zhang, Chengwen Li, et al.
American Journal of Hematology|July 22, 2014
Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndromeRuixian Xing, Chengwen Li, Robert Peter Gale, et al.
Leukemia Research Reports|March 27, 2023
Case of cryptic <i>TNIP1::PDGFRB</i> rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapyShiqiang Qu, Yiru Yan, Chengwen Li, et al.
Cancers|August 28, 2025
Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple MyelomaChenxing Du, Jian Cui, Jingyu Xu, et al.
BMC Medical Genetics|February 18, 2017
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phaseDehui Zou, Shuhua Yi, Rui Cui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[A study of prognostic value of cytogenetics in patients with primary myelofibrosis]Bing Li, Junqing Xu, Zefeng Xu, et al.
Leukemia & Lymphoma|June 24, 2023
Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and <i>FGFR1</i> rearrangementYiru Yan, Shiqiang Qu, Jinqin Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2009
Cellular immune response to cryptic epitopes during therapeutic gene transferChengwen Li, Kevin Goudy, Matt Hirsch, et al.
American Journal of Hematology|August 19, 2014
Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosisBing Li, Junqing Xu, Chengwen Li, et al.
Pageof 20